Page last updated: 2024-09-02

fingolimod hydrochloride and Fibrosarcoma

fingolimod hydrochloride has been researched along with Fibrosarcoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hammond-McKibben, D; Hugo, R; Lake, P; Tart-Risher, N; Weetall, M; Zhang, J1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Fibrosarcoma

ArticleYear
A high-capacity quantitative mouse model of drug-mediated immunosuppression based on rejection of an allogeneic subcutaneous tumor.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:3

    Topics: Animals; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Everolimus; Fibrosarcoma; Fingolimod Hydrochloride; Graft Rejection; Graft Survival; Histocompatibility; Immunity, Cellular; Immunosuppression Therapy; Immunosuppressive Agents; Mice; Mice, Inbred Strains; Mice, Nude; Models, Immunological; Neoplasm Transplantation; Propylene Glycols; Sirolimus; Sphingosine; T-Lymphocytes; Transplantation, Homologous; Tumor Cells, Cultured

2001